Page last updated: 2024-10-24

candesartan and Edema-Proteinuria-Hypertension Gestosis

candesartan has been researched along with Edema-Proteinuria-Hypertension Gestosis in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nonn, O1
Fischer, C1
Geisberger, S1
El-Heliebi, A1
Kroneis, T1
Forstner, D1
Desoye, G1
Staff, AC1
Sugulle, M1
Dechend, R1
Pecks, U1
Kollmann, M1
Stern, C1
Cartwright, JE1
Whitley, GS1
Thilaganathan, B1
Wadsack, C1
Huppertz, B1
Herse, F1
Gauster, M1

Other Studies

1 other study available for candesartan and Edema-Proteinuria-Hypertension Gestosis

ArticleYear
Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia.
    Hypertension (Dallas, Tex. : 1979), 2021, 05-05, Volume: 77, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Benzimidazoles; Biphenyl Comp

2021